Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue:
Total revenue	$ 140,141	$ 5,091
Operating expenses:
Cost of product revenue	15,624	628
Research and development	30,928	27,259
Selling, general and administrative	20,920	62,961
Total operating expenses	67,472	90,848
Income (loss) from operations	72,669	(85,757)
Other expense (income):
Amortization of debt issuance costs and discount	2,994	1,589
Interest income	(3,954)	(1,415)
Interest expense	3,130	5,198
Other income	0	(3)
Warrant liabilities fair value adjustment	3,166	(22,301)
Derivative liability fair value adjustment	154	(1,316)
Total other expense (income)	5,490	(18,248)
Income (loss) before taxes	67,179	(67,509)
Income tax (expense) benefit	(138)	4,700
Net income (loss)	$ 67,041	$ (62,809)
Net income (loss) per share attributable to common stockholders - basic
Net income (loss) per share -basic	$ 1.4	$ (1.47)
Net income (loss) per share attributable to common stockholders -diluted
Net income (loss) per share -diluted	$ 1.39	$ (1.47)
Weighted average common shares outstanding – basic and diluted
Basic	47,852,833	42,613,510
Diluted	48,390,582	42,613,510
Product Revenue, Net
Revenue:
Total revenue	$ 1,044	$ 4,988
License Agreement Revenue
Revenue:
Total revenue	$ 139,097	$ 103